Selective PPARγ modulator diosmin improves insulin sensitivity and promotes browning of white fat

[1]  Yiyun Cheng,et al.  A fluorinated peptide with high serum- and lipid-tolerence for the delivery of siRNA drugs to treat obesity and metabolic dysfunction. , 2022, Biomaterials.

[2]  Ji-qiu Wang,et al.  Local hyperthermia therapy induces browning of white fat and treats obesity , 2022, Cell.

[3]  A. Than,et al.  Transdermal Photothermal-Pharmacotherapy to Remodel Adipose Tissue for Obesity and Metabolic Disorders. , 2022, ACS nano.

[4]  U. Dianzani,et al.  Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study , 2021, BioMed research international.

[5]  R. Serra,et al.  Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial , 2021, Nutrients.

[6]  F. Hamel,et al.  A Selective PPARγ Modulator Reduces Hepatic Fibrosis , 2020, Biology.

[7]  M. Helmy,et al.  The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis , 2020, Molecular Biology Reports.

[8]  S. M. Borghi,et al.  Diosmin Treats Lipopolysaccharide-Induced Inflammatory Pain and Peritonitis by Blocking NF-κB Activation in Mice. , 2020, Journal of natural products.

[9]  Hesham H. Taha,et al.  Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways. , 2020, European journal of pharmacology.

[10]  Fernando Lizcano,et al.  The Beige Adipocyte as a Therapy for Metabolic Diseases , 2019, International journal of molecular sciences.

[11]  T. Zubilewicz,et al.  Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis , 2019, Molecules.

[12]  Lawrence A Leiter,et al.  Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. , 2019, The lancet. Diabetes & endocrinology.

[13]  Fares E. M. Ali,et al.  Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  Á. Kot-Wasik,et al.  Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency , 2018, Oxidative medicine and cellular longevity.

[15]  L. Qiang,et al.  PPAR&ggr; deacetylation dissociates thiazolidinedione’s metabolic benefits from its adverse effects , 2018, The Journal of clinical investigation.

[16]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[17]  D. Krewski,et al.  Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future , 2018, Critical reviews in toxicology.

[18]  Zhen Gu,et al.  Locally Induced Adipose Tissue Browning by Microneedle Patch for Obesity Treatment. , 2017, ACS nano.

[19]  L. Rui,et al.  Brown and Beige Adipose Tissues in Health and Disease. , 2017, Comprehensive Physiology.

[20]  Juei-Tang Cheng,et al.  Antihyperglycaemic action of diosmin, a citrus flavonoid, is induced through endogenous β‐endorphin in type I‐like diabetic rats , 2017, Clinical and experimental pharmacology & physiology.

[21]  S. Yasmin,et al.  Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present. , 2017, European journal of medicinal chemistry.

[22]  S. Farmer,et al.  Browning of White Adipose Tissue with Roscovitine Induces a Distinct Population of UCP1+ Adipocytes. , 2016, Cell metabolism.

[23]  P. Scherer,et al.  Targeting adipose tissue in the treatment of obesity-associated diabetes , 2016, Nature Reviews Drug Discovery.

[24]  F. A. Neves,et al.  GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice , 2016, PloS one.

[25]  P. Griffin,et al.  PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue , 2016, Diabetes.

[26]  F. Quelle,et al.  Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress. , 2016, American journal of physiology. Heart and circulatory physiology.

[27]  S. Kuang,et al.  Biodegradable Polymeric Microsphere-Based Drug Delivery for Inductive Browning of Fat , 2015, Front. Endocrinol..

[28]  Bruce M. Spiegelman,et al.  Brown and Beige Fat: Physiological Roles beyond Heat Generation. , 2015, Cell metabolism.

[29]  H. Budge,et al.  The Ontogeny of Brown Adipose Tissue. , 2015, Annual review of nutrition.

[30]  A. Chauhan,et al.  Endothelial PPAR-&ggr; Protects Against Vascular Thrombosis by Downregulating P-Selectin Expression , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[31]  L. Sidossis,et al.  Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. , 2015, The Journal of clinical investigation.

[32]  Yong Ryoul Yang,et al.  A Novel Non-agonist Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand UHC1 Blocks PPARγ Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity* , 2014, The Journal of Biological Chemistry.

[33]  Guojian Yin,et al.  Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice by inhibiting the activation of the nuclear factor-κB. , 2014, International journal of clinical and experimental pathology.

[34]  Alexander S. Banks,et al.  Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch , 2014, Cell.

[35]  J. Heeren,et al.  Adipose tissue browning and metabolic health , 2014, Nature Reviews Endocrinology.

[36]  M. Lazar,et al.  Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ , 2013, Proceedings of the National Academy of Sciences.

[37]  P. Seale,et al.  Brown and beige fat: development, function and therapeutic potential , 2013, Nature Medicine.

[38]  S. Sultana,et al.  Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model. , 2013, Toxicology letters.

[39]  J. M. Suh,et al.  PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.

[40]  D. Accili,et al.  Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ , 2012, Cell.

[41]  B. Spiegelman,et al.  Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.

[42]  B. Spiegelman,et al.  Development of insulin resistance in mice lacking PGC-1α in adipose tissues , 2012, Proceedings of the National Academy of Sciences.

[43]  Shingo Kajimura,et al.  PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. , 2012, Cell metabolism.

[44]  Hong Wang,et al.  The Multi-Level Action of Fatty Acids on Adiponectin Production by Fat Cells , 2011, PloS one.

[45]  Scott A. Busby,et al.  Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation , 2011, Nature.

[46]  M. J. Chalmers,et al.  Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands , 2010, Nature.

[47]  S. Haulon,et al.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. , 2007, Cell metabolism.

[48]  M. Artwohl,et al.  Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells , 2005, Thrombosis and Haemostasis.

[49]  I. Niopas,et al.  Simultaneous reversed-phase high-performance liquid chromatographic method for the determination of diosmin, hesperidin and naringin in different citrus fruit juices and pharmaceutical formulations. , 2003, Journal of pharmaceutical and biomedical analysis.

[50]  C. Caristi,et al.  Flavonoids detection by HPLC-DAD-MS-MS in lemon juices from Sicilian cultivars. , 2003, Journal of agricultural and food chemistry.

[51]  J. Vertommen,et al.  The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients. , 1999, Diabetes, nutrition & metabolism.

[52]  O. Meyer.  Safety and Security of Daflon 500 mg in Venous Insufficiency and in Hemorrhoidal Disease , 1994, Angiology.